Selective Fluorescent Nonpeptidic Antagonists For Vasopressin V2 GPCR: Application To Ligand Screening and Oligomerization Assays.

S Loison, M Cottet, H Orcel, H Adihou…

Index: Journal of Medicinal Chemistry, , vol. 55, # 20 p. 8588 - 8602

Full Text: HTML

Citation Number: 21

Abstract

... Journal of Medicinal Chemistry. ... G protein-coupled receptors (GPCRs) constitute the largest family of transmembrane signaling molecules in the human genome and represent the most important class of therapeutic targets to the pharmaceutical industry.(1-3) It is of importance ...

Related Articles:

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2, 3, 4, 5-tetrahydro-1H-1, 5- …

[Matsuhisa, Akira; Koshio, Hiroyuki; Sakamoto, Kenichiro; Taniguchi, Nobuaki; Yatsu, Takeyuki; Tanaka, Akihiro Chemical and Pharmaceutical Bulletin, 1998 , vol. 46, # 10 p. 1566 - 1579]

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2, 3, 4, 5-tetrahydro-1H-1, 5- …

[Chemical and Pharmaceutical Bulletin, , vol. 46, # 10 p. 1566 - 1579]

A Scalable Process for the Synthesis of 2-Methyl-1, 4, 5, 6-tetrahydroimidazo [4, 5-d][1] benzazepine Monohydrate and 4-[(Biphenyl-2-ylcarbonyl) amino] benzoic Acid: …

[Tsunoda, Takashi; Yamazaki, Atsuki; Mase, Toshiyasu; Sakamoto, Shuichi Organic Process Research and Development, 2005 , vol. 9, # 5 p. 593 - 598]

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2, 3, 4, 5-tetrahydro-1H-1, 5- …

[Chemical and Pharmaceutical Bulletin, , vol. 46, # 10 p. 1566 - 1579]

More Articles...